Forsta AP Fonden Has $8.97 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Forsta AP Fonden reduced its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,100 shares of the biotechnology company’s stock after selling 200 shares during the quarter. Forsta AP Fonden’s holdings in Axon Enterprise were worth $8,974,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of AXON. Geode Capital Management LLC boosted its stake in Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP increased its position in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after acquiring an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC raised its stake in shares of Axon Enterprise by 13.9% in the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after acquiring an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after purchasing an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment bought a new position in Axon Enterprise in the 3rd quarter valued at $200,000. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the transaction, the insider now directly owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on AXON. JMP Securities upped their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Northland Securities raised their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $524.85.

Axon Enterprise Trading Up 2.1 %

NASDAQ AXON opened at $653.43 on Friday. Axon Enterprise, Inc. has a one year low of $247.04 and a one year high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market cap of $49.82 billion, a P/E ratio of 168.85, a P/E/G ratio of 6.09 and a beta of 1.04. The stock’s 50-day moving average is $619.32 and its 200-day moving average is $479.00.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.